Author:
Zhang Pengfei,Zeng Ping,Lai Christopher K.C.,Ip Margaret,To Kenneth K.W.,Zuo Zhong,Xia Jiang,Leung Sharon S.Y.
Funder
Hang Seng University of Hong Kong
Clinical Trials Fund, Canadian Institutes of Health Research
University Grants Committee Research Grants Council
General Research Fund of Shanghai Normal University
Health and Medical Research Fund
Hong Kong Baptist University
Reference52 articles.
1. 2021 Antibacterial Agents in Clinical and Preclinical Development: An Overview and Analysis;WHO,2022
2. Emergence of Colistin-resistant Bacteria in Humans Without Colistin Usage: A New Worry and Cause for Vigilance;Olaitan,2016
3. Synthetic biology of modular endolysins;Gerstmans;Biotechnol. Adv.,2018
4. The advantages and challenges of using endolysins in a clinical setting;Murray;Viruses,2021